[Purpose/significance] Under the novel coronavirus epidemics, it has become the general consensus by government and scientific discipline to establish and improve the open data platform and data sharing mechanism, to response the global public health challenge and to promote the construction of local public health emergency management data sharing capacity.[Method/process] First, the data sharing policy and actions in previous public health emergencies were examined. Then, based on the investigation of data sharing practices such as peer-reviewed journals, preprint, data repositories, clinical trial registration platform and genome/structure data center, this paper analyzed the current situation of COVID-19 data sharing. Finally, it discussed the advantages, disadvantages and obstacles of different data sharing mechanisms in public health emergencies.[Result/conclusion] The COVID-19 data sharing degree was obviously improved, but it had not reached the norm. Technical, motivational, economic, political, legal and ethical factors were barriers to data sharing. China should enhance the ability of data sharing in public health emergencies from the aspects of strategy, infrastructure, stakeholder and ethics.
Cui Yuhong
,
Wang Sa
. Research on Data Sharing Mechanisms in Novel Coronavirus Public Health Emergency[J]. Library and Information Service, 2020
, 64(15)
: 104
-111
.
DOI: 10.13266/j.issn.0252-3116.2020.15.013
[1] PISANI E, GHATAURE A, MERSON L.Data sharing in public health emergencies[EB/OL]. [2020-03-10].https://www.glopid-r.org/wp-content/uploads/2017/02/data-sharing-in-public-health-emergencies-case-studies-workshop-reportv2.pdf.
[2] Data sharing in public health emergencies: learning lessons from past outbreaks[EB/OL]. [2020-03-10].https://www.glopid-r.org/wp-content/uploads/2017/02/data-sharing-in-public-health-emergencies-case-studies-workshop-reportv2.pdf.
[3] ENSERINK M.Calling all coronavirus researchers: keep sharing, stay open[J].Nature,2020,578(7793): 7.
[4] YOZWIAK N, SCHAFFNER S F, SABETI P C.Data sharing: make outbreak research open access[J].Nature,2015,518(7540): 477-479.
[5] Boosting access to disease data[J]. Nature, 2006, 442(7106):957-957.
[6] SHU Y, MCCAULEY J. GISAID: global initiative on sharing all influenza data-from vision to reality[J]. Euro surveill,2017,22(13):30494.
[7] LITTLER K, BOON W M, CARSON G,et al.Progress in promoting data sharing in public health emergencies[J].Bull world health organ,2017,95(4):243.
[8] WELLCOME TRUST.Statement on data sharing in public health emergencies[EB/OL].[2020-03-10]. https://wellcome.ac.uk/press-release/statement-data-sharing-public-health-emergencies.
[9] TAICHMAN D B, BACKUS J, BAETHGE C, et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors[J]. Annals of internal medicine, 2016, 164(7): 505-506.
[10] A guide to sharing the data and benefits of public health surveillance[EB/OL].[2020-03-20]. https://www.chathamhouse.org/sites/default/files/publications/research/2017-05-25-data-sharing-guide.pdf.
[11] MOORTHY V, RESTREPO A M H, PREZIOSI M P, et al. Data sharing during the novel coronavirus public health emergency of international concern[J].Bulletin of the World Health Organization. 2020,98(3):1-3.
[12] Sharing research data and findings relevant to the novel coronavirus (nCoV) outbreak[EB/OL].[2020-03-01].https://wellcome.ac.uk/press-release/sharing-research-data-and-findings-relevant-novel-coronavirus-covid-19-outbreak.
[13] COVID 19 Public Health Emergency of International Concern (PHEIC) global research and innovation forum: towards a research roadmap[EB/OL]. [2020-03-04].https://www.who.int/blueprint/priority-diseases/key-action/Global_Research_Forum_FINAL_VERSION_for_web_14_feb_2020.pdf?ua=1.
[14] PRADHAN P, PANDEY A K, MISHA A, et al. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag[EB/OL]. [2020-03-01].https://www.biorxiv.org/content/10.1101/2020.01.30.927871v1.full.pdf.
[15] HARDEMAN M. Coronavirus research on figshare[EB/OL]. [2020-03-13]. https://doi.org/10.6084/m9.figshare.c.4836594.v8.
[16] GOPAL A D, WALLACH J D, AMINAWUNG J A, et al. Adherence to the International Committee of Medical Journal Editors’(ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals[J]. Trials, 2018, 19(1): 1-13.
[17] 赵文明, 宋述慧, 陈梅丽,等.2019新型冠状病毒信息库[J].遗传,2020,42(2):212-221.
[18] LU R, ZHAO X, LI J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. The lancet, 2020,395(10224): 565-574.
[19] 伯格曼.大数据、小数据、无数据:网络世界的数据学术[M]. 孟小峰,张祎,赵尔平,等译.北京:机械工业出版社, 2017.
